Regpara cinacalcet regulatory update

Japan approved the 12.5 mg tablet of hypercalcemia drug Regpara cinacalcet from Kyowa. The 25 and 75 mg tablets of Regpara are already marketed to treat hypercalcemia in patients with parathyroid canc...